Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies

PHASE4CompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
Parkinson's Disease DementiaDementia With Lewy Bodies
Interventions
DRUG

Memantine

20mg once daily oral dose

DRUG

Placebo

Daily oral dose

Trial Locations (1)

80804

DE001, Munich

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT00855686 - Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies | Biotech Hunter | Biotech Hunter